NDC 36987-2514
Bayberry
Bayberry
Bayberry is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Morella Cerifera Pollen.
| Product ID | 36987-2514_ca9dfb3b-60b5-4a0b-83ff-990c5959c205 |
| NDC | 36987-2514 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bayberry |
| Generic Name | Bayberry |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | MORELLA CERIFERA POLLEN |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-2514-3
30 mL in 1 VIAL, MULTI-DOSE (36987-2514-3)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-2514-2 [36987251402]
Bayberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2514-4 [36987251404]
Bayberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2514-3 [36987251403]
Bayberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2514-1 [36987251401]
Bayberry INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| MORELLA CERIFERA POLLEN | .05 g/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
NDC Crossover Matching brand name "Bayberry" or generic name "Bayberry"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-2509 | Bayberry | Bayberry |
| 36987-2510 | Bayberry | Bayberry |
| 36987-2511 | Bayberry | Bayberry |
| 36987-2512 | Bayberry | Bayberry |
| 36987-2513 | Bayberry | Bayberry |
| 36987-2514 | Bayberry | Bayberry |
| 36987-2515 | Bayberry | Bayberry |
| 36987-2516 | Bayberry | Bayberry |
Trademark Results [Bayberry]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BAYBERRY 86460255 4839903 Live/Registered |
NATIONAL CHRISTMAS PRODUCTS, INC. 2014-11-20 |
 BAYBERRY 78097979 2728209 Dead/Cancelled |
SAMSONITE IP HOLDINGS S.A.R.L. 2001-12-12 |
 BAYBERRY 73738318 1522668 Dead/Cancelled |
GENERAL MILLS, INC. 1988-07-05 |
 BAYBERRY 73545518 1430458 Dead/Cancelled |
FARRIS, CHRISTOPHER H. 1985-06-28 |
 BAYBERRY 72260666 0844412 Dead/Expired |
LANE LIMITED 1966-12-13 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.